Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Effect of variables in endotoxin presentation on endotoxin reactivity in the Limulus Amoebocyte Lysate Assay (CROSBI ID 573322)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Hoppe, Kimberly A. ; Hađina, Suzana ; Adamcakova-Dodd, Andrea ; Weiss, Jerrold P. ; Thorne, Peter S. Effect of variables in endotoxin presentation on endotoxin reactivity in the Limulus Amoebocyte Lysate Assay // American journal of respiratory and critical care medicine / Jacob Iasha Sznajder (ur.). 2011. str. A3294-A3294

Podaci o odgovornosti

Hoppe, Kimberly A. ; Hađina, Suzana ; Adamcakova-Dodd, Andrea ; Weiss, Jerrold P. ; Thorne, Peter S.

engleski

Effect of variables in endotoxin presentation on endotoxin reactivity in the Limulus Amoebocyte Lysate Assay

The Limulus Amoebocyte Lysate (LAL) Assay is widely used in occupational and environmental health studies to assess exposures to endotoxin (lipopolysaccharide, LPS, or lipooligosaccharide, LOS), a recognized bacterial trigger of innate immunity and a causal agent for a variety of environmental lung diseases. However, it is not known if endotoxin reactivity in the LAL assay varies depending upon how endotoxin is physically presented, i.e., as aggregates of extracted and purified endotoxin vs. as integral membrane components of whole bacteria or shed “blebs” and if this parallels differences in the pro- inflammatory potency of endotoxin seen in vitro and in vivo.14C-LOS was metabolically labeled using an acetate auxotroph of Neisseria meningitidis serogroup B and used as part of intact bacteria, purified membrane blebs, and as aggregates of purified LOS (Post D et al, 2005). 14C-LOS content of each was determined by quantifying LOS-specific 14C-3-OH fatty acids. Effects of increasing doses of 14C-LOS- containing bacteria, blebs, or LOS aggregates were tested in: 1) the LAL assay ; 2) in vivo in C3HeB/FeJ mice, monitoring induced airway inflammation (e.g., accumulation of neutrophils in bronchoalveolar lavage) following intra- nasal instillation ; and 3) in vitro, using HEK293 cells ± CD14, MD-2, TLR4, monitoring LOS-triggered cell activation by the extracellular accumulation of IL-8, measured by ELISA. Doses of 14C-LOS were measured by scintillation counting. Results: Differences in endotoxin potency were observed in each of the 3 assays depending on how LOS was presented with the following rank order of reactivity: in LAL assay: membrane blebs > LOS aggregates > intact bacteria ; Airway inflammation: bacteria > blebs > LOS aggregates ; Activation of HEK/CD14/MD-2/TLR4 cells: LOS aggregates > blebs > bacteria. Maximum differences in potency ranged from 6-fold (LAL) to >10-fold (in vitro and in vivo pro-inflammatory activity). These findings demonstrate that how endotoxin is physically presented significantly affects endotoxin reactivity in the LAL assay and in endotoxin-induced pro-inflammatory responses in vitro and in vivo.

endotoxin ; LAL assay ; HEK-293 cells

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

A3294-A3294.

2011.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

American journal of respiratory and critical care medicine

Jacob Iasha Sznajder

New York (NY):

1073-449X

1535-4970

Podaci o skupu

American Thoracic Society 2011

poster

13.05.2011-18.05.2011

Denver (CO), Sjedinjene Američke Države

Povezanost rada

Javno zdravstvo i zdravstvena zaštita, Veterinarska medicina

Indeksiranost